Until recently we used dopamine in the treatment of shock in a manner similar to that reported by Schr6der and colleagues (Ramdohr et al. 1971 , Ramdohr et al. 1973 , Ramdohr et al. 1975 up to a maximum of 10 jg/kg per min by intravenous injection. In many patients with cardiac shock small doses improve the circulation, but in patients with septic shock and during severe circulatory insufficiency after hemorrhage and trauma, dopamine in doses up to 10 jg/kg per min may not improve the circulation, so that the combined use of dopamine with adrenaline or isoprenaline is sometimes advocated. We had been unwillingto use dopamine in high dosage because of the likelihood of producing increasing amounts of a-adrenergic stimulation. However, the good results obtained by Thompson et al. (1974) encouraged us to make the present study on dogs using a dosage of dopamine up to 320 jg/kg per min. In a previous study (Reinecke et al. 1975 ) we investigated the coronary hxemodynamics of dogs given dopamine in doses up to 10 jg/kg per min.
Until recently we used dopamine in the treatment of shock in a manner similar to that reported by Schr6der and colleagues (Ramdohr et al. 1971 , Ramdohr et al. 1973 , Ramdohr et al. 1975 up to a maximum of 10 jg/kg per min by intravenous injection. In many patients with cardiac shock small doses improve the circulation, but in patients with septic shock and during severe circulatory insufficiency after hemorrhage and trauma, dopamine in doses up to 10 jg/kg per min may not improve the circulation, so that the combined use of dopamine with adrenaline or isoprenaline is sometimes advocated. We had been unwillingto use dopamine in high dosage because of the likelihood of producing increasing amounts of a-adrenergic stimulation. However, the good results obtained by Thompson et al. (1974) encouraged us to make the present study on dogs using a dosage of dopamine up to 320 jg/kg per min. In a previous study (Reinecke et al. 1975) we investigated the coronary hxemodynamics of dogs given dopamine in doses up to 10 jg/kg per min.
Methods
The investigations were performed on 18 mongrel dogs. Anesthesia was introduced and maintained with piritramide, a synthetic opioid. The animals were normoventilated with nitrous oxide-oxygen mixture using an Engstr6m respirator. Muscle relaxation was obtained with small doses of nortoxiferin. The parameters of acid-base-equilibrium were frequently measured and corrected for deviations from normal values. Only peripheral vessels were prepared and cannulation was facilitated with heparinization and fluoroscopic control. The pressure in the aorta and the pulmonary artery, the central venous and left ventricular pressures were measured with external transducers (Statham P 23DG). The left ventricular maximum dp/dt was obtained from a pressure measurement using a catheter tip mranometer (Miller PC 350) and a RC-coupled differentiator. The cardiac output was determined intermittently by thermodilution. The outflow of the coronary sinus was measured by a Pitot-catheter (Hensel & Bretschneider 1970) . The arterial coronary sinus oxygen content difference was obtained using a CO-oxymeter (IL). The total peripheral resistance (TPR) and the coronary vascular resistance (CVR), myocardial oxygen consumption (MVO2), left ventricular work (LVW) and efficiency of heart work (EME) were calculated (Yang et al. 1974) . After obtaining base-line values (Cl) in a circulatory steady state, dopamine was infused by a calibrated pump. Each experiment started with the lowest dose; after 15 min time the dose was doubled. The total dose range tested was 2.5 to 320.0 jig/kg per min. After 15 minutes 320.0 pg/kg per min the dopamine infusion was stopped. All circulatory parameters were measured or calculated after 15 minutes continuous infusion of the given dopamine dose. The investigations were continued after the termination of the dopamine infusion. A paired t test was used for statistical evaluation of the results.
Results
The heart rate (Fig 1) was increased beginning with a dose of 10 jg/kg per min dopamine. The maximum effect was reached with 40-160 jg/kg per min. Between 20 and 40 jg/kg per min severe arrhythmias were often seen in the electrocardiogram. The cardiac index (Fig 1) The mean aortic pressure (Fig 2) rose beginning with 10 jig/kg per min dopamine. The pressure effect of 20 jg/kg per min was not marked. A maximum rise in aortic pressure occurred with 40-60 jg/kg per min dopamine. Up to a dose of 40 gg/kg per min the total peripheral resistance remained constant or rose only slightly (40 jig/kg per min). A steep dose-dependent rise in total peripheral resistance occurred with 80 and 160 jg/kg per min dopamine. A slight decrease in central venous pressure was measured beween 10 and 320 jg/kg per min dopamine (Fig 2) .
The pulmonary artery and left ventricular end diastolic pressure (Fig 3) remained almost unchanged between 2.5 and 20.0 jig/kg per min dopamine. Both parameters were increased with 40 pg/kg per min and showed steep elevations in the higher doses.
The maximum dp/dt ( Fig 3) increase with 10 jg/kg per min dopamine. A maximum of approximately +4000 mmHg was reached with 40 jg/kg per min. Only a slight increase in coronary blood flow was produced with 2.5 and 5.0 jg/kg per min dopamin (Fig 4) . Between 10 and 40 pg/kg per min dose-dependent increase in coronary flow occurred. The coronary vascular resistance (Fig 4) doses of dopamine remains purely pressure d pendent. Beginning with the 220 jig/kg per m dose an increase in coronary sinus oxygen conte (Fig 4) was observed. The oxygen consumption the left ventricle and the cardiac work was do dependent from 2.5 to 40 jg/kg per min dopamii ( Fig 5) . The relationship of the oxygen consum tion and left ventricular work up to 40 jig/kg p min showed that a slight decrease in myocardi efficiency occurred but this was not statistical significant. Higher doses of dopamine (80-3 jig/kg per min) produced a marked decrease in tl efficiency of cardiac work.
In studying the dose-related influence of high doses of dopamine a maximum circulatory stim lation was usually observed between 40 and I jig/kg per min intravenously. A further increa in dose usually lessened the maximum effect o served. With 320 jg/kg per min dopamine a le pronounced stimulation usually occurred in cor parison with doses between 80-160 jig/kg per mi After stopping the infusion of high doses of dop mine a marked cardiovascular stimulation st remained. The mean arterial pressure reached tl control values 15 minutes after the end of ti dopamine infusion, whereas the total peripher resistance, the heart rate, the maximum dp/d pulmonary artery and left ventricular end diastol pressure, and myocardial blood flow remainc elevated, though showing a distinct tendency 1 A PAP decrease. There was no improvement in cardiac index, stroke volume index, coronary vascular resistance, myocardial oxygen consumption and efficiency 15 minutes after 320 jig/kg per min of dopamine.
Discussion
From the results of our experiments it seems relatively safe to use dopamine in a dose range up to 40 jg/kg per min if a severe tachycardia can be avoided. However, our results are derived from experiments on anxesthetized dogs and we are not able to give any information about side-effects in case of dopamine treatment lasting longer than 15 minutes. The results described with the lower dopamine doses are quite comparable with the literature (Horwitz et al. 1962 , Brooks 1969 , Nayler et al. 1971 , Ramdohr et al. 1971 , Cobb et al. 1972 , Goldberg 1972 , Crexelles et al. 1973 , Goldberg et al. 1973 , Ramdohr et al. 1973 , Vatner et al. 1973 , Neubaur et al. 1975 , Ramdohr et al. 1975 indicates, again, that dopamine might be superior to other catecholamines, even in the higher dose range. However, more experimental and clinical data have to be obtained. We should also consider the influence of higher dopamine doses on myocardial oxygen supply. Dopamine increased the myocardial blood flow due to coronary vasodilatation and higher doses act additionally on the perfusion pressure. The decrease in arteriocoronary-sinus oxygen indicates some degree of a coronary 'luxury' perfusion. After consuming the coronary reserve, i.e. maximum vasodilatation, a further flow increase looks purely pressure dependent and the heart will meet the elevated oxygen demand due to the increased work. However, it should be emphasized that our results were obtained on healthy dogs. In most clinical applications of dopamine we have to consider a decreased coronary reserve. All patients in shock, with hypertension, or with a previous infarction in the higher age group have to be considered as a coronary risk. Dopamine may influence the main determinants ofmyocardial oxygen demand: heart rate, contractility and left ventricular outflow impedance but, using higher doses of dopamine in a coronary patient the oxygen demand of the myo-I I cardium might be increased over the supply. We believe that tachycardia and an increasing rate of cardiac arrhythmia will limit the dose of dopamine in these patients.
Summary
We measured the action of dopamine given intravenously at dosage ranging from 2.5 to 320 ig/kg per min in closed chest anasthetized dogs. Dopamine produced a dose-dependent increase in heart rate, cardiac index, mean arterial pressure, total peripheral resistance, pulmonary artery pressure, left ventricular end diastolic pressure, coronary flow and myocardial oxygen consumption. At dopamine dosage of 80-320 jg/kg per min, the coronary vascular resistance, the stroke volume index, the efficiency of heart work and the central venous pressure are all decreased. The maximum effect of dopamine on the circulation was seen at a dose between 40 and 80 gg/kg per min. Professor BrUickner: I presented here the first results of a project still in progress. We are going to extend the experiments including norepinephrine and also sodium nitroprusside.
Professor Goldberg: On the basis of these results, you have made a clinical decision not to use more than 10 jg/kg per min of dopamine in man, is that correct ?
Professor Bruckner: In a severe circulatory insufficiency 10 ,ug/kg per min dopamine does not produce any sufficient effect. If we don't get severe tachycardia we are using higher doses of dopamine, up to 30,ug/kg per min.
Professor Goldberg: May I ask a question? Suppose you have a patient whose blood pressure is 60 or 50 mm/Hg and you have given him 20 pg/kg per min of dopamine and the pressure is only 55in other words, you have not increased the afterload and there is no pronounced increase in heart ratewould you then put the dose up? Is it possible to say that there is a fixed upper limit?
When 100 jig/kg per min is given, is there more toxicity, or is it that the patient simply is not responding and the dose response curve is shifted to the right? In other words, I am a little concerned about a rigid upper limit, particularly on the basis of dog data, and that is why I am asking about it. Suppose the pressure does not rise, suppose there is no tachycardia, and suppose you have already given 20; will you stop then, and add norepinephrine ?
Professor Bruckner: I would prefer to give higher doses of dopamine rather than a combination of dopamine and norepinephrine. However, I would not like to elevate the systolic pressure over 100 mmHg. It is quite difficult to give upper limits of dosage in dopamine treatment. The basic conditions have to be considered. Patients in septic shock tolerate higher doses of dopamine often without any signs of tachycardia. However, if there is a need for 100 ,ug/kg per min dopamine to keep the circulation, the survival rate will always be poor.
Professor Goldberg: I think that is a very important point. I agree, never raise the pressure more than you have to. I think that we should observe the patient very carefully and keep the pressure as low as possible, because afterload is not good.
What you clearly showed was the bad effects of an increased afterload. In fact, you actually got a descending limb, it seems to me, which I have not seen before.
Professor Briickner: It looks like a model for reproducing shock using high doses of norepinephrine.
Mr P E Ghadiali (London): You will forgive me, sir, if I have missed the point altogether, but when you said that the coronary blood flow was increased due to the lowered peripheral vascular resistance in the heart muscle, how did you come to that conclusion? The cardiac output had gone up, the heart was pumping more blood, with a pulsatile flow; how did you measure the peripheral vascular resistance in the coronary circulation under these circumstances.
Professor Bruckner: The coronary vascular resistance was calculated from the mean diastolic pressure in the aorta and the myocardial blood flow. In the case of a higher oxygen demand of the myocardium, the myocardial flow is autoregulate via changes in vascular resistance. In coronary patients that mechanism fails to work and the flow will be mainly pressure regulated. The compensation of a changing oxygen need via the arterial coronary sinus oxygen is limited. An increasing arterial coronary sinus oxygen often indicates an insufficient oxygen supply. In our experiments we did not observe that. There is some discussion about a coronary vasoconstrictive effect of dopamine. Some of my colleagues found there was a slight increase in coronary vascular resistance, especially in the 10 jug/kg per min dose range. We have not seen this in our dogs.
Dr D J Robson (London): On the question of the decrease in coronary vascular resistance, is this always a good thing? If you have a patient who has a critical coronary artery stenosis, and very many patients whom you find in surgical shock have, may you not in fact precipitate an infarct, at least theoretically, by decreasing the general coronary resistance and decreasing perfusion to their stenosed segment ?
Professor BrUckner: If you have a normal corovary vascular system, without any stenosis, a reduction in resistance will not produce pathophysiological changes. However, if you have a reduced flow reserve due to a coronary sclerosis the occurrence of a coronary steal has to be discussed, when using coronary dilators or increasing the oxygen demand of the myocardium abruptly. Due to the pressure/flow relationship the oxygen supply of some parts of the myocardium is quite on the edge. If the perfusion pressure can be elevated sufficiently a deficiency between oxygen demand and oxygen need may develop especially in the subendocardial layers. In the coronary patient a critical situation may develop suddenly and therefore I would like to be very careful about using high doses of dopamine in that case.
Professor Goldberg: I might just say a few words about coronary flow. All these drugs, like norepinephrine and dopamine, if injected directly into the coronary artery in a large dose, will cause vasoconstriction, but when given intravenously they have mixed effects on coronary flow. One is dilatation due to the positive inotropic effect on oxygen requirements, so it is very difficult to dissect the direct effects on coronary flow. A smaller dose of dopamine may dilate the coronary vessels when injected intra-arterially. So there is the old problem of a biphasic action.
